Medigus Intangible Assets

The latest intangible assets for MDGS is $19M as of December 2023. That compares with $22M in the prior-year period — down 13.8% year over year. Investors often review this figure alongside Medigus's historical trend and sector peers before judging valuation or financial health.

Over the past year, MDGS's intangible assets moved from $22M to $19M — a 13.8% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Medigus's operating scale or balance-sheet position.

A intangible assets figure of $19M for MDGS is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting MDGS's intangible assets ($19M), review year-over-year change from $22M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Medigus's intangible assets against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.